K F Laserson1, A S Kenyon, T A Kenyon, T Layloff, N J Binkin. 1. Division of TB Elimination, National Centers for HIV/AIDS, STD and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia 30333, USA. kel4@cdc.gov
Abstract
SETTING: The prevalence of substandard anti-tuberculosis drugs is unknown. To maximize the effectiveness of tuberculosis (TB) control efforts, simple, inexpensive drug quality screening methods are needed. DESIGN:Isoniazid (INH) and rifampin (RMP) single- and fixed-dose combination (FDC) formulations were collected from selected TB programs and pharmacies in Colombia, Estonia, India, Latvia, Russia and Vietnam. Samples were screened using a recently developed thin-layer chromatography (TLC) kit. All abnormal samples and a 40% random sample of normal formulations were further analyzed using confirmatory techniques. Samples outside of 85% to 115% of stated content, and/or containing compounds other than the stated drug, were defined as being substandard. RESULTS: Overall, 10% (4/40) of all samples, including 13% (4/30) RMP samples, contained <85% of stated content. More FDCs (5/24, 21%) than single-drug samples (2/16, 13%) were substandard. A comparison of TLC with the confirmatory analysis for RMP analysis showed a sensitivity of 100% (4/4), a specificity of 92% (24/26), a positive predictive value (PPV) of 67% (4/6), and a negative predictive value (NPV) of 100% (24/24). An analysis of INH showed a specificity of 90% (9/10). However, sensitivity, PPV, and NVP could not be determined. CONCLUSION: A substantial number of anti-tuberculosis drugs from several countries, in particular FDCs, were found to be substandard. Such drugs may contribute to the creation of drug-resistant TB. TLC is an effective, convenient, and inexpensive method for the detection of substandard drugs.
RCT Entities:
SETTING: The prevalence of substandard anti-tuberculosis drugs is unknown. To maximize the effectiveness of tuberculosis (TB) control efforts, simple, inexpensive drug quality screening methods are needed. DESIGN:Isoniazid (INH) and rifampin (RMP) single- and fixed-dose combination (FDC) formulations were collected from selected TB programs and pharmacies in Colombia, Estonia, India, Latvia, Russia and Vietnam. Samples were screened using a recently developed thin-layer chromatography (TLC) kit. All abnormal samples and a 40% random sample of normal formulations were further analyzed using confirmatory techniques. Samples outside of 85% to 115% of stated content, and/or containing compounds other than the stated drug, were defined as being substandard. RESULTS: Overall, 10% (4/40) of all samples, including 13% (4/30) RMP samples, contained <85% of stated content. More FDCs (5/24, 21%) than single-drug samples (2/16, 13%) were substandard. A comparison of TLC with the confirmatory analysis for RMP analysis showed a sensitivity of 100% (4/4), a specificity of 92% (24/26), a positive predictive value (PPV) of 67% (4/6), and a negative predictive value (NPV) of 100% (24/24). An analysis of INH showed a specificity of 90% (9/10). However, sensitivity, PPV, and NVP could not be determined. CONCLUSION: A substantial number of anti-tuberculosis drugs from several countries, in particular FDCs, were found to be substandard. Such drugs may contribute to the creation of drug-resistant TB. TLC is an effective, convenient, and inexpensive method for the detection of substandard drugs.
Authors: D Nabirova; G Schmid; R Yusupova; M Kantarbayeva; S I Ismailov; D Moffett; R W O Jähnke; J P Nuorti Journal: Int J Tuberc Lung Dis Date: 2017-10-01 Impact factor: 2.373
Authors: Roger K Verbeeck; Gunar Günther; Dan Kibuule; Christian Hunter; Tim W Rennie Journal: Eur J Clin Pharmacol Date: 2016-06-15 Impact factor: 2.953
Authors: Patricia Tabernero; Mayfong Mayxay; María Julia Culzoni; Prabha Dwivedi; Isabel Swamidoss; Elizabeth Louise Allan; Maniphone Khanthavong; Chindaphone Phonlavong; Chantala Vilayhong; Sengchanh Yeuchaixiong; Chanvilay Sichanh; Sivong Sengaloundeth; Harparkash Kaur; Facundo M Fernández; Michael D Green; Paul N Newton Journal: Am J Trop Med Hyg Date: 2015-04-20 Impact factor: 2.345
Authors: Agnes Binagwaho; Roger Bate; Michel Gasana; Corine Karema; Yves Mucyo; John Patrick Mwesigye; Floribert Biziyaremye; Cameron T Nutt; Claire M Wagner; Paul Jensen; Amir Attaran Journal: PLoS Med Date: 2013-07-02 Impact factor: 11.069